http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208385-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bae7cf399c53b51787e575edaf8b820 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90 |
| filingDate | 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78bb7774e318858d136201b18d68e2c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df05e5d2980c498fe390a7909fa06e81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d64f0da0ad2ea1baee6efff520e9bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3bf7edf912431b0cdf508aa90aa84f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015a09c268791f0abb2cc2c9a4cef4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d8b1b619ebfbba55da53b1daaf81211 |
| publicationDate | 2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-11208385-B2 |
| titleOfInvention | N-substituted imidazole carboxylate compound, preparation method and use |
| abstract | An N-substituted imidazole carboxylate compound is of formula (I). In formula (I), C* is an R-type chiral carbon atom, R1 and R2 are independently selected from H, methyl, ethyl, cyclopropyl, cyclobutyl or isopropyl, or R1 and R2 form a C2˜5 alkylenyl group; R3 is a substituted or unsubstituted C1-18 saturated or unsaturated aliphatic hydrocarbon or aromatic hydrocarbon, in which the aliphatic hydrocarbon comprises a straight chain, branched chain or cyclic aliphatic hydrocarbyl. The compound or pharmaceutically acceptable salts thereof can be used to prepare central inhibitory drugs that exert sedative, hypnotic and/or anesthetic effects on humans or animals, and can produce rapid and reversible anesthetic effects, and can be rapidly metabolized into an inactive etomidate acid, and after drug withdrawal, the wake-up quality is good; and the body's corticosteroid function can be rapidly recovered after a single administration or continuous administration. |
| priorityDate | 2017-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 395.